Envestnet Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.39M | Sell |
14,502
-768
| -5% | -$232K | ﹤0.01% | 2276 |
|
|
2025
Q1 | $5.06M | Buy |
15,270
+269
| +2% | +$89.1K | ﹤0.01% | 2117 |
|
|
2024
Q4 | $4.63M | Buy |
15,001
+334
| +2% | +$103K | ﹤0.01% | 2154 |
|
|
2024
Q3 | $3.11M | Buy |
14,667
+213
| +1% | +$45.2K | ﹤0.01% | 2392 |
|
|
2024
Q2 | $4.05M | Buy |
14,454
+9,616
| +199% | +$2.69M | ﹤0.01% | 2169 |
|
|
2024
Q1 | $1.29M | Sell |
4,838
-103
| -2% | -$27.5K | ﹤0.01% | 2855 |
|
|
2023
Q4 | $1.14M | Buy |
4,941
+708
| +17% | +$164K | ﹤0.01% | 2842 |
|
|
2023
Q3 | $618K | Buy |
4,233
+1,981
| +88% | +$289K | ﹤0.01% | 3135 |
|
|
2023
Q2 | $520K | Buy |
2,252
+432
| +24% | +$99.8K | ﹤0.01% | 3183 |
|
|
2023
Q1 | $441K | Buy |
1,820
+539
| +42% | +$131K | ﹤0.01% | 3226 |
|
|
2022
Q4 | $372K | Buy |
+1,281
| New | +$372K | ﹤0.01% | 3283 |
|
|
2013
Q4 | – | Sell |
-58
| Closed | -$13K | – | 2514 |
|
|
2013
Q3 | $13K | Buy |
+58
| New | +$13K | ﹤0.01% | 1614 |
|